TIMP1 and neoplasm: Consistent with this pro-tumorigenic role of TIMP-1, several clinical studies have demonstrated that elevated TIMP-1 levels in tumor tissue or peripheral blood are associated with poor clinical outcomes in a range of malignancies [147,148,149,150,151,152,153,154].